pemetrexed

Generic: pemetrexed disodium

Labeler: qilu pharmaceutical co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pemetrexed
Generic Name pemetrexed disodium
Labeler qilu pharmaceutical co., ltd.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

pemetrexed disodium hemipentahydrate 100 mg/4mL

Manufacturer
Qilu Pharmaceutical Co., Ltd.

Identifiers & Regulatory

Product NDC 67184-0503
Product ID 67184-0503_0dc735ab-c4c9-4e19-bb80-8a439be7208c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204890
Listing Expiration 2026-12-31
Marketing Start 2022-05-25

Pharmacologic Class

Classes
folate analog metabolic inhibitor [epc] folic acid metabolism inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 671840503
Hyphenated Format 67184-0503

Supplemental Identifiers

RxCUI
1728072 1728077
UNII
F4GSH45R4C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pemetrexed (source: ndc)
Generic Name pemetrexed disodium (source: ndc)
Application Number ANDA204890 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/4mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (67184-0503-1) / 4 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

pemetrexed disodium hemipentahydrate (100 mg/4mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0dc735ab-c4c9-4e19-bb80-8a439be7208c", "openfda": {"unii": ["F4GSH45R4C"], "rxcui": ["1728072", "1728077"], "spl_set_id": ["46a9b89d-7135-4e0c-b8e4-52580554769b"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (67184-0503-1)  / 4 mL in 1 VIAL", "package_ndc": "67184-0503-1", "marketing_start_date": "20220525"}], "brand_name": "Pemetrexed", "product_id": "67184-0503_0dc735ab-c4c9-4e19-bb80-8a439be7208c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "67184-0503", "generic_name": "Pemetrexed disodium", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pemetrexed", "active_ingredients": [{"name": "PEMETREXED DISODIUM HEMIPENTAHYDRATE", "strength": "100 mg/4mL"}], "application_number": "ANDA204890", "marketing_category": "ANDA", "marketing_start_date": "20220525", "listing_expiration_date": "20261231"}